Literature DB >> 1322715

Altered surface antigen expression on peripheral blood mononuclear cells in cats infected with feline immunodeficiency virus.

K Ohno1, T Watari, R Goitsuka, H Tsujimoto, A Hasegawa.   

Abstract

Expression of CD4, CD8, IL-2 receptor alpha chain (IL-2R alpha), and MHC class II (MHC-II) on peripheral blood mononuclear cells were examined in cats infected with feline immunodeficiency virus (FIV). CD4/CD8 T cell ratio in FIV-infected cats was slightly decreased, as compared with that in specific-pathogen-free (SPF) cats. However, there was no statistical differences between them. The number of circulating IL-2R alpha+ cells in FIV-infected cats was higher than that in healthy cats, whereas induction of IL-2R alpha expression by concanavalin A (Con A) stimulation was depressed in FIV-infected cats. By using two-color cytofluorometry, Con A-induced enhancement of IL-2R alpha expression was found to be reduced in both CD4+ and CD8+ populations in PBMC from FIV-infected cats. The circulating MHC-II+ cells were also increased in FIV-infected cats. Furthermore, the induction of IL-2R alpha expression on PBMC after Con A-stimulation significantly depressed by FIV inoculation in vitro. These results suggest that FIV activates PBMC in vivo via direct and/or indirect mechanisms, leading to the unresponsive state of T cells to further stimuli in vitro.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322715     DOI: 10.1292/jvms.54.517

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  9 in total

1.  Detection of apoptosis induced in peripheral blood lymphocytes from cats infected with feline immunodeficiency virus.

Authors:  Y Momoi; T Mizuno; Y Nishimura; Y Endo; K Ohno; T Watari; R Goitsuka; H Tsujimoto; A Hasegawa
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 2.  Vaccination of Immunocompromised Cats.

Authors:  Katrin Hartmann; Karin Möstl; Albert Lloret; Etienne Thiry; Diane D Addie; Sándor Belák; Corine Boucraut-Baralon; Herman Egberink; Tadeusz Frymus; Regina Hofmann-Lehmann; Hans Lutz; Fulvio Marsilio; Maria Grazia Pennisi; Séverine Tasker; Uwe Truyen; Margaret J Hosie
Journal:  Viruses       Date:  2022-04-28       Impact factor: 5.818

Review 3.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

4.  Induction of apoptosis in a T lymphoblastoid cell line infected with feline immunodeficiency virus.

Authors:  K Ohno; Y Okamoto; T Miyazawa; T Mikami; T Watari; R Goitsuka; H Tsujimoto; A Hasegawa
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

5.  The role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progression.

Authors:  E Holznagel; R Hofmann-Lehmann; C M Leutenegger; K Allenspach; S Huettner; U Forster; E Niederer; H Joller; B J Willett; U Hummel; G L Rossi; J Schüpbach; H Lutz
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

6.  Lymphokine-activated killer cell transplantation after anti-cancer treatment in two aged cats.

Authors:  Noritaka Maeta; Katsutoshi Tamura; Hiroshi Takemitsu; Masahiro Miyabe
Journal:  Open Vet J       Date:  2019-05-13

Review 7.  Clinical aspects of feline immunodeficiency and feline leukemia virus infection.

Authors:  Katrin Hartmann
Journal:  Vet Immunol Immunopathol       Date:  2011-07-21       Impact factor: 2.046

Review 8.  Clinical aspects of feline retroviruses: a review.

Authors:  Katrin Hartmann
Journal:  Viruses       Date:  2012-10-31       Impact factor: 5.048

9.  FIV infection of IL-2-dependent and -independent feline lymphocyte lines: host cells range distinctions and specific cytokine upregulation.

Authors:  D L Lerner; C K Grant; A de Parseval; J H Elder
Journal:  Vet Immunol Immunopathol       Date:  1998-10-23       Impact factor: 2.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.